SCHEMBL8330752

SCHEMBL8330752

COc1ccc(C(OCC(CCCCO[Si](C)(C)C(C)(C)C)OC(=O)c2ccccc2)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
SLC6A11 P48066 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
CYP19A1 P11511 1/20 0.37
MAPK1 P28482 1/20 0.37
PLA2G2A P14555 2/20 0.37
PLA2G10 O15496 1/20 0.37
PLA2G1B P04054 1/20 0.37
PLA2G5 P39877 1/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PNLIP P16233 1/20 0.36
KIF11 P52732 3/20 0.36
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8328095 0.85 MEN1 (0.42) SLC6A1L3MBTL1SLC6A11ALDH1A1GAA
SCHEMBL8331026 0.83 TK1 (0.38) SLC6A1SLC6A11PLA2G2APLA2G10PLA2G1B
SCHEMBL14197473 0.81 ADRB2 (0.45) ALDH1A1MAPK1MEN1KMT2AMAPT
SCHEMBL25034637 0.81 TDP1 (0.41) ALDH1A1MEN1KMT2AMAPTPNLIP
SCHEMBL29894147 0.78 PLA2G2A (0.35) SLC6A1SLC6A11PLA2G2APLA2G10PLA2G1B
SCHEMBL27081229 0.76 MAPT (0.42) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL27081233 0.76 MAPT (0.42) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL7721078 0.76 TBXAS1 (0.44) SLC6A1SLC6A11KMT2AMAPTNPC1
SCHEMBL21647836 0.76 TBXAS1 (0.41) L3MBTL1ALDH1A1GAACYP19A1MAPK1
SCHEMBL21647837 0.76 TBXAS1 (0.41) L3MBTL1ALDH1A1GAACYP19A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0523978-B1 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides JOLLA PHARMA (US) 1999-05-12 EP disclosed
US-5874552-A Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides LA JOLLA PHARMACEUTICAL COMPANY (US) 1999-02-23 US disclosed
US-5786512-A Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides LAJOLLA PHARMACEUTICAL COMPANY (US) 1998-07-28 US disclosed
US-5726329-A Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides LA JOLLA PHARMACEUTICAL COMPANY (US) 1998-03-10 US disclosed
US-5391785-A Intermediates for providing functional groups on the 5' end of oligonucleotides LA JOLLA PHARMACEUTIAL COMPANY (US) 1995-02-21 US disclosed
EP-0523978-A1 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides LA JOLLA PHARMACEUTICAL (US) 1993-01-20 EP disclosed